Severe congenital dyserythropoietic anaemia type I: prenatal management, transfusion support and alpha‐interferon therapy

We report a case of congenital dyserythropoietic anaemia, type I, with severe pre‐ and postnatal manifestations. Exchange transfusions were required for fetal anaemia (3·5 g/dl) at 28 and 30 weeks of gestation. Transfusions were administered at birth (Caesarean section at week 35) and at regular int...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 2000-08, Vol.110 (2), p.420-423
Hauptverfasser: Parez, N., Dommergues, M., Zupan, V., Chambost, H., Fieschi, J. B., Delaunay, J., Miélot, F., Cramer, E. M., Dommergues, J.‐P., Wickramasinghe, S. N., Tchernia, G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We report a case of congenital dyserythropoietic anaemia, type I, with severe pre‐ and postnatal manifestations. Exchange transfusions were required for fetal anaemia (3·5 g/dl) at 28 and 30 weeks of gestation. Transfusions were administered at birth (Caesarean section at week 35) and at regular intervals thereafter. At 14 months, α‐interferon therapy was initiated (106 units three times a week). This resulted in stabilization of the haemoglobin at or above 11 g/dl and a reduction in the percentage of erythroblasts with ultrastructurally abnormal heterochromatin. After 9 months, the dose of α‐interferon was decreased to 106 units twice a week. No relapse of anaemia was noted during an additional 4 months of follow‐up.
ISSN:0007-1048
1365-2141
DOI:10.1046/j.1365-2141.2000.02168.x